featured
Fracture Risk Reduction With and Safety of Osteoporosis Treatment Compared With Placebo or an Active Comparator in Postmenopausal Women
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMJ: British Medical Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials
BMJ 2023 May 02;381(xx)e068033, MN Händel, I Cardoso, C von Bülow, JF Rohde, A Ussing, SM Nielsen, R Christensen, JJ Body, ML Brandi, A Diez-Perez, P Hadji, MK Javaid, WF Lems, X Nogues, C Roux, S Minisola, A Kurth, T Thomas, D Prieto-Alhambra, SL Ferrari, B Langdahl, B AbrahamsenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.